What does Life Sciences Partners invest in?
Life Sciences Partners invests most often at Series B and Series A (100% of the rounds on record).
Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
4 rounds on record
Mostly Series B and Series A: 100% of its rounds
Led 1 rounds
Every round we can evidence, newest first4 appearances
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as Life Sciences Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Life Sciences Partners put money into.
Life Sciences Partners invests most often at Series B and Series A (100% of the rounds on record).
4 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Dec 2019.
Its most recent investments on record: ImCheck Therapeutics (Series B, Dec 2019), XyloCor (Series A, Dec 2018) and BioClin Therapeutics (Series B, Mar 2017).
The median round it joins is $32M.
No investments in the last 12 months; the latest was in Dec 2019.
Most often Sofinnova Investments (2 rounds together).
Life Sciences Partners is a growth equity firm.
From 4 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it